for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
A new world is possible.
Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
Lawyers tackled legal and data privacy issues to deliver Covid test kits in the UK
German drugs group to snap up biopharmaceuticals group in innovation push
German drugmaker believes jab could still be used for some age groups or as booster
Chemical group says it wants to reduce risk of litigation after court dismisses $2bn plan to settle cancer claims
German group expects new drugs to plug revenue gap as it pledges to increase profits
Stefan Oelrich acknowledges challenge of its two bestselling products going off patent
Collaboration will help German group deliver several hundred million doses after lagging behind competitors
Paying up to $4bn for US-based biotech is unlikely to be transformational
German group acquires US-based AskBio to strengthen its lucrative pharma business
It is hard to see what would trigger a near-term turnround in investor sentiment
German group warns coronavirus crisis to hit harder than expected as it writes down assets in agricultural business
Unpredictable juries expose potential hazards of German conglomerate’s approach
German group will spend up to $10.9bn to settle lawsuits over Roundup
Shareholders would be within their right to agitate for radical change.
Chief executive of German group says deal will ‘bring a long period of uncertainty to an end’
Shortages of antimalarials and inhalers feared as purchases spike
Two shareholders seek damages for directors’ alleged personal responsibility for corporate misconduct
Rise in plaintiffs comes as German chemicals group reports 19% jump in sales
Farmers voiced concerns on social media over alleged data sharing
German chemicals group faces surge in plaintiffs alleging cancer link to Roundup
Farmer’s claims could expand pharma group’s legal woes over Monsanto acquisition
Too many giants of the Dax are suffering from self-inflicted wounds
Deal will create second-biggest player in sector as German chemicals group looks to reorganise
German chemicals and pharma group has been under strain amid claims weedkiller causes cancer
Deal values BlueRock Therapeutics at $1bn